Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP625813.RAPNj7O-8AtzGbkoGN4NPVAvgisecOw4DoX15DNZZVsm8130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP625813.RAPNj7O-8AtzGbkoGN4NPVAvgisecOw4DoX15DNZZVsm8130_assertion type Assertion NP625813.RAPNj7O-8AtzGbkoGN4NPVAvgisecOw4DoX15DNZZVsm8130_head.
- NP625813.RAPNj7O-8AtzGbkoGN4NPVAvgisecOw4DoX15DNZZVsm8130_assertion description "[Metformin has been used as first-line treatment in patients with type 2 diabetes, and is reported to reduce cancer risk and progression by activating the liver kinase B1 (LKB1)-AMP-activated protein kinase (AMPK) pathway.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP625813.RAPNj7O-8AtzGbkoGN4NPVAvgisecOw4DoX15DNZZVsm8130_provenance.
- NP625813.RAPNj7O-8AtzGbkoGN4NPVAvgisecOw4DoX15DNZZVsm8130_assertion evidence source_evidence_literature NP625813.RAPNj7O-8AtzGbkoGN4NPVAvgisecOw4DoX15DNZZVsm8130_provenance.
- NP625813.RAPNj7O-8AtzGbkoGN4NPVAvgisecOw4DoX15DNZZVsm8130_assertion SIO_000772 23526220 NP625813.RAPNj7O-8AtzGbkoGN4NPVAvgisecOw4DoX15DNZZVsm8130_provenance.
- NP625813.RAPNj7O-8AtzGbkoGN4NPVAvgisecOw4DoX15DNZZVsm8130_assertion wasDerivedFrom befree-20140225 NP625813.RAPNj7O-8AtzGbkoGN4NPVAvgisecOw4DoX15DNZZVsm8130_provenance.
- NP625813.RAPNj7O-8AtzGbkoGN4NPVAvgisecOw4DoX15DNZZVsm8130_assertion wasGeneratedBy ECO_0000203 NP625813.RAPNj7O-8AtzGbkoGN4NPVAvgisecOw4DoX15DNZZVsm8130_provenance.